Your browser doesn't support javascript.
loading
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers.
Leiendecker, Lukas; Neumann, Tobias; Jung, Pauline S; Cronin, Shona M; Steinacker, Thomas L; Schleiffer, Alexander; Schutzbier, Michael; Mechtler, Karl; Kervarrec, Thibault; Laurent, Estelle; Bachiri, Kamel; Coyaud, Etienne; Murali, Rajmohan; Busam, Klaus J; Itzinger-Monshi, Babak; Kirnbauer, Reinhard; Cerroni, Lorenzo; Calonje, Eduardo; Rütten, Arno; Stubenrauch, Frank; Griewank, Klaus G; Wiesner, Thomas; Obenauf, Anna C.
Afiliação
  • Leiendecker L; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Neumann T; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Jung PS; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Cronin SM; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Steinacker TL; Quantro Therapeutics, Vienna, Austria.
  • Schleiffer A; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Schutzbier M; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Mechtler K; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Kervarrec T; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Laurent E; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Bachiri K; Institute of Molecular Biotechnology (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
  • Coyaud E; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Murali R; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Busam KJ; Institute of Molecular Biotechnology (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
  • Itzinger-Monshi B; The Gregor Mendel Institute of Molecular Plant Biology of the Austrian Academy of Sciences (GMI), Vienna BioCenter (VBC), Vienna, Austria.
  • Kirnbauer R; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
  • Cerroni L; Institute of Molecular Biotechnology (IMBA), Vienna BioCenter (VBC), Vienna, Austria.
  • Calonje E; The Gregor Mendel Institute of Molecular Plant Biology of the Austrian Academy of Sciences (GMI), Vienna BioCenter (VBC), Vienna, Austria.
  • Rütten A; Department of Pathology, University Hospital Center of Tours, University of Tours, Tours, France.
  • Stubenrauch F; PRISM INSERM U1192, Université de Lille, Villeneuve d'Ascq, France.
  • Griewank KG; PRISM INSERM U1192, Université de Lille, Villeneuve d'Ascq, France.
  • Wiesner T; PRISM INSERM U1192, Université de Lille, Villeneuve d'Ascq, France.
  • Obenauf AC; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Discov ; 13(1): 70-84, 2023 01 09.
Article em En | MEDLINE | ID: mdl-36213965
ABSTRACT
The skin is exposed to viral pathogens, but whether they contribute to the oncogenesis of skin cancers has not been systematically explored. Here we investigated 19 skin tumor types by analyzing off-target reads from commonly available next-generation sequencing data for viral pathogens. We identified human papillomavirus 42 (HPV42) in 96% (n = 45/47) of digital papillary adenocarcinoma (DPA), an aggressive cancer occurring on the fingers and toes. We show that HPV42, so far considered a nononcogenic, "low-risk" HPV, recapitulates the molecular hallmarks of oncogenic, "high-risk" HPVs. Using machine learning, we find that HPV-driven transformation elicits a germ cell-like transcriptional program conserved throughout all HPV-driven cancers (DPA, cervical carcinoma, and head and neck cancer). We further show that this germ cell-like transcriptional program, even when reduced to the top two genes (CDKN2A and SYCP2), serves as a fingerprint of oncogenic HPVs with implications for early detection, diagnosis, and therapy of all HPV-driven cancers.

SIGNIFICANCE:

We identify HPV42 as a uniform driver of DPA and add a new member to the short list of tumorigenic viruses in humans. We discover that all oncogenic HPVs evoke a germ cell-like transcriptional program with important implications for detecting, diagnosing, and treating all HPV-driven cancers. See related commentary by Starrett et al., p. 17. This article is highlighted in the In This Issue feature, p. 1.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neoplasias Ósseas / Neoplasias da Mama / Adenocarcinoma Papilar / Neoplasias do Colo do Útero / Adenocarcinoma de Células Claras / Infecções por Papillomavirus Tipo de estudo: Screening_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Neoplasias Ósseas / Neoplasias da Mama / Adenocarcinoma Papilar / Neoplasias do Colo do Útero / Adenocarcinoma de Células Claras / Infecções por Papillomavirus Tipo de estudo: Screening_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article